Citations

Showing 10 of 108104 citations.

VASP Regulates NK Cell Lytic Granule Convergence
Wilton, Katelynn M. , Billadeau, Daniel D.

Mayo Clinic

The Journal of Immunology | October 3, 2018 | Volume: 201 | Issue: 10 | Pages: 2899-2909

10.4049/jimmunol.1800254 | PMID 30282752 Get It

Abstract NK cells eliminate viral-infected and malignant cells through a highly orchestrated series of cytoskeletal rearrangements, resulting in the release of cytolytic granule contents toward the target cell. Central to this process is the convergence of cytolytic granules to a common point, the microtubule-organizing center (MTOC), before delivery to the synapse. In this study, we show that vasodialator-stimulated phosphoprotein (VASP), an actin regulatory protein, localizes to the cytolytic synapse, but surprisingly, shows no impact on conjugate formation or synaptic actin accumulation despite being required for human NK cell–mediated killing. Interestingly, we also find that a pool of VASP copurifies with lytic granules and localizes with lytic granules at the MTOC. Significantly, depletion of VASP decreased lytic granule convergence without impacting MTOC polarization. Using the KHYG-1 cell line in which lytic granules are in a constitutively converged state, we find that either VASP depletion or F-actin destabilization promoted spreading of formerly converged granules. Our results demonstrate a novel requirement for VASP and actin polymerization in maintaining lytic granule convergence during NK cell–mediated killing.
Effect of Early Surgery vs Physical Therapy on Knee Function Among Patients With Nonobstructive Meniscal Tears
Noorduyn, Julia C. A. , Butter, Ise K., Gast, Arthur de , Saris, Daniël B.F. , Poolman, Rudolf W. , Graaf, Victor A. van de , Willigenburg, Nienke Willemien , Mol, Ben W , Twisk, Jos W. R.

Mayo Clinic

JAMA | October 3, 2018 | Volume: 320 | Issue: 13 | Pages: 1328

10.1001/jama.2018.13308 | PMID 30285177 Get It

Economic evaluation of a pharmacogenomic multi-gene panel test to optimize anti-hypertension therapy: simulation study
Kelley, Eli F. , Snyder, Eric M., Alkhatib, Nimer S. , Snyder, Scott C., Sprissler, Ryan , Olson, Thomas P. , Akre, Monica K. , Abraham, Ivo

Mayo Clinic

Journal of Medical Economics | October 3, 2018 | Volume: 21 | Issue: 12 | Pages: 1246-1253

10.1080/13696998.2018.1531011 | PMID 30280614 Get It

A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging
Heckman, Alexander , McCain, Josiah D. , Cowart, Jennifer B. , Garland, Jeffrey, Heckman, Alexander J, Maniaci, Michael J. , Garland, Jeffrey L, Helgeson, Scott A.

Mayo Clinic

Oxford Medical Case Reports | October 3, 2018 | Volume: 2018 | Issue: 10 | Pages: No page available

10.1093/omcr/omy072 | PMID 30302263 Get It

Quality of Life Within the First 6 Months of Vestibular Schwannoma Diagnosis With Implications for Patient Counseling
Carlson, Matthew L. , Tombers, Nicole M. , Kerezoudis, Panagiotis , Celda, María Peris, Lohse, Christine M. , Link, Michael J.

Mayo Clinic

Otology & Neurotology | October 3, 2018 | Volume: 39 | Issue: 10 | Pages: e1129-e1136

10.1097/mao.0000000000001999 | PMID 30239440 Get It

Objective: To evaluate quality-of-life (QOL) in patients with sporadic vestibular schwannoma (VS) with particular focus on those recently diagnosed. Study Design: Cross-sectional survey, Penn Acoustic Neuroma Quality of Life (PANQOL) instrument. Setting: Acoustic Neuroma Association and a single tertiary referral center. Patients: Patients with sporadic VS. Main Outcome Measures: Domain-specific and total PANQOL scores comparing treatment modalities after adjusting for baseline covariates of interest. Results: Among all 1,288 respondents there were 229 (18%) who were recently diagnosed and had not yet selected a treatment modality, 303 (24%) who were observed, 185 (14%) who underwent radiosurgery alone, 507 (39%) who underwent microsurgery alone, and 64 (5%) who underwent radiosurgery and microsurgery. After adjusting for covariates of interest, total PANQOL scores were highest for the observation cohort (65; 95% CI 62–68), lowest for patients treated with multimodality therapy (56; 51–61) and those recently diagnosed (58; 55–62), and intermediate for those who received microsurgery alone (60; 58–62) and radiosurgery alone (61; 57–64) (global comparison, p = 0.001). When comparing groups that received single-modality therapy, there were no statistically significant differences in total PANQOL scores at short (0–5 yr), intermediate (6–10 yr), or long-term (≥11 yr) follow-up after adjusting for baseline covariates (all, p > 0.05). Conclusion: A new diagnosis of VS frequently imparts significant anxiety on the patient and leads to a temporary reduction in QOL. Notably, anxiety domain QOL scores among patients with newly diagnosed VS are poorer than patients who have observed their tumor for 6 months or longer. When feasible, an initial period of observation may afford patients valuable time to reconcile with the new diagnosis, to learn more about treatment options, and to discover whether there is tumor growth. In turn, this valuable information can be used to inform sound decision-making regarding tumor management.
Effect of percutaneous paravalvular leak closure on hemolysis
Panaich, Sidakpal , Maor, Elad , Reddy, Gautam , Raphael, Claire E. , Hagler, Donald J. , Reeder, Guy S., Rihal, Charanjit S. , Eleid, Mackram F. , Panaich, Sidakpal S , Cabalka, Allison, Hagler, Donald J , Eleid, Mackram F , Raphael, Claire , Maor, Elad , Cabalka, Allison K. , Rihal, Charanjit S.

Mayo Clinic

Catheterization and Cardiovascular Interventions | October 3, 2018 | Volume: 93 | Issue: 4 | Pages: 713-719

10.1002/ccd.27917 | PMID 30280481 Get It

AbstractObjectiveTo study the effect of percutaneous paravalvular leak closure on hemolysis.BackgroundAlthough transcatheter PVL closure reduces heart failure and mortality in symptomatic patients with paravalvular leaks (PVL), little is known about its effect on hemolysis.MethodsWe retrospectively analyzed patients undergoing transcatheter mitral or aortic PVL closure (January 2005–December 2016) at Mayo Clinic. Patients with anemia or abnormal hemolysis markers (LDH, haptoglobin) were included in the analysis. The primary outcome was defined as hemoglobin increase ≥ 1.5 mg/dL, decrease in LDH above median or improvement in haptoglobin. Univariate and multivariate binary logistic regression modeling were used to determine predictors of successful treatment of hemolysis.ResultsFinal study population included 168 patients (130 [77%] mitral, 38 [23%] aortic PVL). Primary outcome occurred in 70 patients (42%). Hemoglobin increased by 1.74 ± 1.69 mg/dL in patients who reached primary outcome. 57/168 (34%) patients required blood transfusion prior to PVL closure compared to 35/168 (21%) postprocedure. The mean reduction in LDH was 403 U/L. Multivariate regression showed that patients with mechanical valves were more likely to have successful outcome (P = 0.044).ConclusionPercutaneous PVL closure is associated with modest improvement in hemolysis markers, increase in hemoglobin levels and reduction in blood transfusion requirements. This benefit is most significant in patients with mechanical valves.
The Rapidly Assessed Predictor of Intraoperative Damage (RAPID) Score: An In-Clinic Predictive Model for High-Grade Acetabular Chondrolabral Disruption
Hartigan, David E. , Wu, Isabella T. , Desai, Vishal S. , Wijnen, André J. van , Saris, Daniël B.F. , Levy, Bruce A. , Krych, Aaron J. , Wyles, Cody C. , van Wijnen, Andre J , Krych, Aaron J , Hevesi, Mario , Desai, Vishal

Mayo Clinic

Orthopaedic Journal of Sports Medicine | October 3, 2018 | Volume: 6 | Issue: 10 | Pages: No page available

10.1177/2325967118799068 | PMID 30302348 Get It

Background: The preoperative assessment of cartilage lesions is critical to surgical planning and decision making. The accurate radiographic determination of acetabular cartilage damage has remained elusive for modern imaging modalities, including magnetic resonance imaging (MRI) and magnetic resonance arthrography (MRA). While risk factors have been individually described, no multivariable system exists for predicting high-grade cartilage damage. Purpose: To determine the preoperative predictors of grade 3 to 4 acetabular labrum articular disruption (ALAD) lesions. Study Design: Case-control study; Level of evidence, 3. Cohort study (diagnosis); Level of evidence, 1. Methods: Retrievable radiographs were reviewed from primary hip arthroscopic procedures performed at 2 high-volume institutions between December 2007 and April 2017. The predictive value of demographic and radiographic factors for the intraoperative documentation of ALAD grade 3 to 4 damage was analyzed and entered into a multivariable model, and a statistically guided scoring system for the damage risk was created using the Akaike information criterion. The scoring system was then prospectively validated on 167 patients who underwent primary hip arthroscopy between April 2017 and February 2018. Results: A total of 652 primary hip arthroscopic procedures in 614 patients (390 female, 224 male; mean age, 33.2 ± 12.5 years; mean body mass index, 26.9 ± 5.5 kg/m 2 ) from 2007 to 2017 were analyzed. Male sex (odds ratio [OR], 3.11; P < .01), age ≥35 years (OR, 1.96; P < .01), cam morphology (alpha angle >55°) (OR, 2.96; P < .01), and Tönnis grade 1 to 2 (grade 1: OR, 4.14; P < .01, and grade 2: OR, 9.29; P < .01) were univariate risk factors for intraoperatively documented high-grade damage. A multivariable scoring system, the Rapidly Assessed Predictor of Intraoperative Damage (RAPID) score (0-5 points), was generated based on sex, Tönnis grade, and cam morphology. Patients with increasing RAPID scores had an increasing risk of damage, with a 10.5% risk for those with 0 points and an 88.0% risk for those with 5 points ( P < .01). The area under the curve was 0.75 for the study group and 0.76 for the validation group ( P = .94). Conclusion: While preoperative MRI has diagnostic value for hip arthroscopic surgery, the RAPID score provides added benefit as a readily employable, in-clinic system for predicting high-grade cartilage damage. The discriminatory value of the RAPID score compares favorably with previous MRI and MRA studies. This information will help the clinician and patient plan for high-grade damage and identify potential targets for cartilage treatment.
Differential expression of interferon‐induced genes and other tissue‐based biomarkers in acute graft‐versus‐host disease vs. lupus erythematosus in skin
Lehman, Julia S. , Dasari, Surendra , Damodaran, Sindhuja Sominidi, Gibson, Lawrence E. , Hashmi, Shahrukh K. , Kenderian, Saad J., Patnaik, Mrinal M. , Litzow, Mark R. , Meves, Alexander , Lehman, Julia S , el‐Azhary, Rokea A. , Hogan, William J. , Lazarus, Hillard M.

Mayo Clinic

Clinical and Experimental Dermatology | October 2, 2018 | Volume: 44 | Issue: 4 | Pages: e81-e88

10.1111/ced.13759 | PMID 30280423 Get It

Risk Factors for Persistent Cognitive Impairment After Critical Illness, Nested Case-Control Study
Sakusic, Amra , Gajić, Ognjen, Singh, Tarun D. , O’Horo, John C. , Jenkins, Gregory D. , Wilson, Gregory , Petersen, Ronald C. , Fryer, John Denis , Jenkins, Gregory, Wilson, Gregory A, O'Horo, John C , Gajic, Ognjen , Kashyap, Rahul , Rabinstein, Alejandro A.

Mayo Clinic

Critical Care Medicine | October 2, 2018 | Volume: 46 | Issue: 12 | Pages: 1977-1984

10.1097/ccm.0000000000003395 | PMID 30222636 Get It

Objectives: Persistent cognitive impairment after critical illness is an important healthcare problem forecasted to worsen in the near future. However, the epidemiology is insufficiently explored. We aimed to determine potentially modifiable risk factors during ICU hospitalization that play a significant role in developing persistent cognitive impairment. Design: An observational case-control study. Settings: Mayo Clinic ICUs between July 1, 2004, and November 20, 2015. Patients: We conducted a study nested in a large cohort of 98,227 adult critically ill patients. Using previously validated computable phenotypes for dementia and cognitive impairment, we determined the onset of cognitive impairment relative to ICU hospitalization and associated risk factors. The primary endpoint of the study was new and persistent cognitive impairment documented between 3 and 24 months after ICU discharge. Interventions: Unadjusted and adjusted analyses were performed to identify potentially modifiable risk factors during ICU hospitalization. Measurements and Main Results: Among 21,923 unique patients identified as cognitively impaired (22% of the entire ICU cohort), 2,428 (2.5%) developed incident new and persistent cognitive dysfunction after the index ICU admission. Compared with age- and sex-matched ICU controls (2,401 pairs), cases had higher chronic illness burden (Charlson Comorbidity Index, 6.2 vs 5.1; p < 0.01), and were more likely to have multiple ICU stays (22% vs 14%; p < 0.01). After adjustment for baseline differences, new and persistent cognitive dysfunction was associated with higher frequency of acute brain failure in the ICU, a higher exposure to severe hypotension, hypoxemia, hyperthermia, fluctuations in serum glucose, and treatment with quinolones or vancomycin. Association with sepsis observed in univariate analysis did not persist after adjustment. Conclusions: Cognitive dysfunction is highly prevalent in ICU patients. Incident new and persistent cognitive impairment is less common but important, potentially preventable problem after critical illness. Chronic comorbidities and number of ICU stays increase the risk of post-ICU cognitive dysfunction irrespective of age. Modifiable ICU exposures were identified as potential targets for future prevention trials.
In Reply:
Simon, James A. , Kingsberg, Sheryl A. , Faubion, Stephanie S. , Larkin, Lisa

Mayo Clinic

Menopause | October 2, 2018 | Volume: 26 | Issue: 2 | Pages: 227-228

10.1097/gme.0000000000001191 | PMID 30204639 Get It